麦角生物碱抑制产后泌乳：一项双盲研究。
Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.
作者信息
Varga L, Lutterbeck P M, Pryor J S, Wenner R, Erb H
出版信息
Br Med J. 1972 Jun 24;2(5816):743-4. doi: 10.1136/bmj.2.5816.743.
Abstract
A double-blind trial was performed in 60 women to establish the effectiveness of an ergot alkaloid, 2-Br-alpha-ergocryptine (ergocryptine; CB 154), in suppressing puerperal lactation and to compare it with stilboestrol and a placebo. At the doses selected ergocryptine and stilboestrol were equally effective.
摘要
对60名女性进行了一项双盲试验，以确定麦角生物碱2-溴-α-麦角隐亭（麦角隐亭；CB 154）在抑制产后泌乳方面的有效性，并将其与己烯雌酚和安慰剂进行比较。在所选择的剂量下，麦角隐亭和己烯雌酚的效果相同。
相似文献
1
Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.麦角生物碱抑制产后泌乳：一项双盲研究。
Br Med J. 1972 Jun 24;2(5816):743-4. doi: 10.1136/bmj.2.5816.743.
2
3
An ergocryptine as a lactation inhibitor.麦角隐亭作为一种泌乳抑制剂。
Gynecol Invest. 1974;5(3):133-8. doi: 10.1159/000301647.
4
[Inhibition of puerperal lactation with ergot alkaloids].[麦角生物碱对产后泌乳的抑制作用]
Schweiz Med Wochenschr. 1972 Sep 9;102(36):1284-5.
5
Serum prolactin and the suppression of lactation.
Br J Obstet Gynaecol. 1976 Sep;83(9):679-82. doi: 10.1111/j.1471-0528.1976.tb00912.x.
6
The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).CB - 154（2 - 溴 - α - 麦角隐亭）对人体催乳素分泌的抑制作用。
J Clin Endocrinol Metab. 1972 Nov;35(5):768-71. doi: 10.1210/jcem-35-5-768.
7
A new approach to the inhibition of puerperal lactation.一种抑制产后泌乳的新方法。
J Obstet Gynaecol Br Commonw. 1973 Nov;80(11):945-51. doi: 10.1111/j.1471-0528.1973.tb02954.x.
8
9
Prolactin inhibition and suppression of puerperal lactation by a Br-erocryptine (CB 154). A comparison with estrogen.溴隐亭（CB 154）对催乳素的抑制作用及对产后泌乳的抑制：与雌激素的比较。
Obstet Gynecol. 1973 Jun;41(6):884-90.
10
The effectiveness of stilboestrol in the suppression on postpartum lactation.己烯雌酚在抑制产后泌乳方面的有效性。
J Obstet Gynaecol Br Commonw. 1968 Mar;75(3):313-5. doi: 10.1111/j.1471-0528.1968.tb02084.x.
引用本文的文献
1
Management of prolactinomas in children and adolescents; which factors define the response to treatment?儿童和青少年泌乳素瘤的管理；哪些因素决定了治疗反应？
Pituitary. 2022 Feb;25(1):167-179. doi: 10.1007/s11102-021-01184-x. Epub 2021 Sep 13.
2
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas.手术是侵袭性泌乳素瘤的安全、有效的一线治疗方式。
Pituitary. 2021 Dec;24(6):955-963. doi: 10.1007/s11102-021-01168-x. Epub 2021 Jun 29.
3
Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis.手术作为催乳素瘤患者一线治疗的可行选择：系统评价和荟萃分析。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e32-41. doi: 10.1210/clinem/dgz144.
4
Treatments for suppression of lactation.抑制泌乳的治疗方法。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD005937. doi: 10.1002/14651858.CD005937.pub3.
5
Pituitary-gonadal axis: historical notes.垂体-性腺轴：历史记录。
Pituitary. 2009;12(3):226-35. doi: 10.1007/s11102-008-0128-0.
6
The history of the treatment of pituitary adenomas.垂体腺瘤的治疗史。
Endocrine. 2005 Oct;28(1):9-26. doi: 10.1385/ENDO:28:1:009.
7
Development of pituitary adenoma treatment--a critical essay.
Pituitary. 1999 Aug;2(2):103-12. doi: 10.1023/a:1009927312197.
8
Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
Eur J Clin Pharmacol. 1982;22(2):181-3. doi: 10.1007/BF00542465.
9
Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.降低和释放催乳素的药物。作用机制及治疗应用。
Drugs. 1983 Apr;25(4):399-432. doi: 10.2165/00003495-198325040-00004.
10
Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.溢乳症：用溴隐亭成功治疗，血浆催乳素水平降低。
Br Med J. 1972 Sep 16;3(5828):669-72. doi: 10.1136/bmj.3.5828.669.
本文引用的文献
1
[2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat].[2-溴-α-麦角隐亭：对大鼠生育力和泌乳的影响]
Experientia. 1968 Nov 15;24(11):1130-1. doi: 10.1007/BF02147804.
2
Oestrogens and puerperal thrombosis.雌激素与产褥期血栓形成
Br Med J. 1968 Dec 21;4(5633):769. doi: 10.1136/bmj.4.5633.769-a.
3
Inhibition of lactation by oestrogens.雌激素对泌乳的抑制作用。
Br Med J. 1968 Nov 9;4(5627):387. doi: 10.1136/bmj.4.5627.387.
4
Puerperal thromboembolism.产褥期血栓栓塞症
Br Med J. 1968 Nov 16;4(5628):451. doi: 10.1136/bmj.4.5628.451-a.
5
Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy.产褥期血栓栓塞与雌激素疗法抑制泌乳的关系。
Br Med J. 1968 Oct 5;4(5622):19-25. doi: 10.1136/bmj.4.5622.19.
6
Increased factor IX levels in puerperium during administration of diethylstilboestrol.在服用己烯雌酚期间产褥期因子IX水平升高。
Br Med J. 1968 Mar 30;1(5595):801-3. doi: 10.1136/bmj.1.5595.801.
7
8
[Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].麦角隐亭和2-溴-α-麦角隐亭对催乳素分泌的抑制作用：对培养垂体的直接作用
Ann Endocrinol (Paris). 1971 Jan-Feb;32(1):188-92.
9
10
Prolactin: evidence that it is separate from growth hormone in human blood.
Science. 1970 Nov 13;170(3959):745-7. doi: 10.1126/science.170.3959.745.
Zotero 插件